Evidence map›Paper›PMID 24026546›Full record

ArticleDiabetes care2014

Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes.

Francesca D'Addio, Paola Maffi, Paolo Vezzulli, Andrea Vergani, Alessandra Mello, Roberto Bassi, Rita Nano, Monica Falautano, Elisabetta Coppi, Giovanna Finzi and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetes care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Impact of Islet Transplantation on Type 1 Diabetes-Related Complication: A Systematic Review.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Benefits and Hurdles of Pancreatic β-Cell Replacement.Stem cells translational medicine · 2022
    Review
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Francesca D'AddioCorresponding author: Paolo Fiorina, paolo.fiorina@childrens.harvard.edu.
Paola Maffi
Paolo Vezzulli
Andrea Vergani
Alessandra Mello
Roberto Bassi
Rita Nano
Monica Falautano
Elisabetta Coppi
Giovanna Finzi
Armando D'Angelo
Isabella Fermo
Fabio Pellegatta
Stefano La Rosa
Giuseppe Magnani
Lorenzo Piemonti
Andrea Falini
Franco Folli
Antonio Secchi
Paolo Fiorina
Harvard University · USVita-Salute San Raffaele University · ITSan Raffaele University of Rome · ITBoston Children's Hospital · USOspedale Bassini · ITThe University of Texas at San Antonio · US

Funding

RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
NIDDK NIH HHS T32 DK007726NIDDK NIH HHS T32DK-007726-28
6 · The paper itself

Abstract

OBJECTIVE Islets after kidney transplantation have been shown to positively affect the quality of life of individuals with type 1 diabetes (T1D) by reducing the burden of diabetes complications, but fewer data are available for islet transplantation alone (ITA). The aim of this study was to assess whether ITA has a positive impact on hemostatic and cerebral abnormalities in individuals with T1D. RESEARCH DESIGN AND METHODS Prothrombotic factors, platelet function/ultrastructure, and cerebral morphology, metabolism, and function have been investigated over a 15-month follow-up period using ELISA/electron microscopy and magnetic resonance imaging, nuclear magnetic resonance spectroscopy, and neuropsychological evaluation (Profile of Mood States test and paced auditory serial addition test) in 22 individuals with T1D who underwent ITA (n = 12) or remained on the waiting list (n = 10). Patients were homogeneous with regard to metabolic criteria, hemostatic parameters, and cerebral morphology/metabolism/function at the time of enrollment on the waiting list. RESULTS At the 15-month follow-up, the group undergoing ITA, but not individuals with T1D who remained on the waiting list, showed 1) improved glucose metabolism; 2) near-normal platelet activation and prothrombotic factor levels; 3) near-normal cerebral metabolism and function; and 4) a near-normal neuropsychological test. CONCLUSIONS ITA, despite immunosuppressive therapy, is associated with a near-normalization of hemostatic and cerebral abnormalities.

Indexed as

HemostasisIslets of Langerhans TransplantationAdultBlood GlucoseBlood PlateletsBrainDiabetes Mellitus, Type 1FemaleHumansImmunosuppressive AgentsMalePilot ProjectsQuality of LifeRetrospective StudiesBlood GlucoseImmunosuppressive Agents

Identifiers

PMID24026546
PMCPMC3867995
OpenAlexW2123747387

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.